1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Pulmonary Arterial Hypertension Market – By Drugs

1.3.2        Asia Pacific Pulmonary Arterial Hypertension Market – By Type

1.3.3        Asia Pacific Pulmonary Arterial Hypertension Market – By Route of Administration

1.3.4        Asia Pacific Pulmonary Arterial Hypertension Market – By Distribution Channel

1.3.5        Asia Pacific Pulmonary Arterial Hypertension Market – By Country

2.           Asia Pacific Pulmonary Arterial Hypertension Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Pulmonary Arterial Hypertension Market – Market Landscape

4.1         Overview

4.2         Asia Pacific PEST Analysis

4.3         Experts Opinion

5.           Asia Pacific Pulmonary Arterial Hypertension Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Incidence of Pulmonary Arterial Hypertension

5.1.2        Rising Approvals of Pulmonary Arterial Hypertension Drugs

5.2         Market Restraints

5.2.1        Side Effects of Drugs Used for Treatment of Pulmonary Arterial Hypertension

5.3         Market Opportunities

5.3.1        Availability of Generics at Affordable Costs Due to Growing Patent Expiration

5.4         Future Trend

5.4.1        Rising Clinical Trials for Drugs Development to Treat Pulmonary Arterial Hypertension

5.5         Impact analysis

6.           Pulmonary Arterial Hypertension Market – Asia Pacific Analysis

6.1         Asia Pacific Pulmonary Arterial Hypertension Market Revenue Forecast and Analysis

7.           Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Drugs

7.1         Overview

7.2         Asia Pacific Pulmonary Arterial Hypertension Market Revenue Share, by Drugs 2021 & 2028 (%)

7.3         Endothelin Receptor Antagonists (ERAs)

7.3.1        Overview

7.3.2        Endothelin Receptor Antagonists (ERAs): Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Prostacyclin and Prostacyclin Analogs

7.4.1        Overview

7.4.2        Prostacyclin and Prostacyclin Analogs: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

7.5         SGC Stimulators

7.5.1        Overview

7.5.2        sGC Stimulators: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Pde-5 Dipsticks

7.6.1        Overview

7.6.2        Pde-5 Dipsticks: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

8.           Asia Pacific Pulmonary Arterial Hypertension Market Analysis and Forecasts to 2028 – by Type

8.1         Overview

8.2         Asia Pacific Pulmonary Arterial Hypertension Market, by Type 2021 & 2028 (%)

8.3         Branded

8.3.1        Overview

8.3.2        Branded: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Generics

8.4.1        Overview

8.4.2        Generics: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Route of Administration

9.1         Overview

9.2         Asia Pacific Pulmonary Arterial Hypertension Market Revenue Share, by Route of Administration 2021 & 2028 (%)

9.3         Oral

9.3.1        Overview

9.3.2        Oral: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Intravenous/ Subcutaneous

9.4.1        Overview

9.4.2        Intravenous/ Subcutaneous: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Inhalational

9.5.1        Overview

9.5.2        Inhalational: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

10.        Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Distribution Channel

10.1      Overview

10.2      Asia Pacific Pulmonary Arterial Hypertension Market Revenue Share, by Distribution Channel 2021 & 2028 (%)

10.3      Hospital Pharmacies and Clinics

10.3.1     Overview

10.3.2     Hospital Pharmacies and Clinics: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Online Pharmacies

10.4.1     Overview

10.4.2     Online Pharmacies: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Retail Pharmacies

10.5.1     Overview

10.5.2     Retail Pharmacies: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.        Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – Country Analysis

11.1      Overview

11.1.1     Asia Pacific: Pulmonary Arterial Hypertension Market, by Country, 2021 & 2028 (%)

11.1.1.1       China: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       China: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3       China: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)

11.1.1.1.4       China: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)

11.1.1.1.5       China Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.1.1.6       China Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)

11.1.1.2       Japan: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       Japan: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3       Japan: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)

11.1.1.2.4       Japan: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)

11.1.1.2.5       Japan: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.1.2.6       Japan: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)

11.1.1.3       India: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       India: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3       India: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)

11.1.1.3.4       India: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)

11.1.1.3.5       India: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.1.3.6       India: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)

11.1.1.4       South Korea: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.1       Overview

11.1.1.4.2       South Korea: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.3       South Korea: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)

11.1.1.4.4       South Korea: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)

11.1.1.4.5       South Korea: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.1.4.6       South Korea: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)

11.1.1.5       Australia: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.1       Overview

11.1.1.5.2       Australia: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.3       Australia: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)

11.1.1.5.4       Australia: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)

11.1.1.5.5       Australia: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.1.5.6       Australia: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)

11.1.1.6       Rest of Asia Pacific: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.1       Overview

11.1.1.6.2       Rest of Asia Pacific: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.3       Rest of Asia Pacific: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)

11.1.1.6.4       Rest of Asia Pacific: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)

11.1.1.6.5       Rest of Asia Pacific: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.1.6.6       Rest of Asia Pacific: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)

12.        Asia Pacific Pulmonary Arterial Hypertension Market – Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Johnson & Johnson

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Gilead Sciences Inc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Bayer AG

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Novartis AG

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      GSK Plc

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Teva Pharmaceutical Industries Ltd

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Lupin Ltd

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Pfizer Inc

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Asia Pacific Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             China Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)

Table 3.             China Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 4.             China Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 5.             China Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Japan Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Japan Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Japan Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Japan Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 10.          India Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)

Table 11.          India Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 12.          India Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 13.          India Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 14.          South Korea Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)

Table 15.          South Korea Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 16.          South Korea Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 17.          South Korea Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Australia Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Australia Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Australia Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Australia Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Rest of Asia Pacific Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Rest of Asia Pacific Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Rest of Asia Pacific Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Rest of Asia Pacific Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 26.          Organic Developments in the Asia Pacific pulmonary arterial hypertension market

Table 27.          Inorganic Developments in the Asia Pacific pulmonary arterial hypertension market

Table 28.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Asia Pacific Pulmonary Arterial Hypertension Market Segmentation

Figure 2.           Asia Pacific Pulmonary Arterial Hypertension Market – By Country

Figure 3.           Asia Pacific Pulmonary Arterial Hypertension Market Overview

Figure 4.           Prostacyclin and Prostacyclin Analogs Segment Held Largest Share by Drugs of the Asia Pacific Pulmonary Arterial Hypertension Market

Figure 5.           China to Show Significant Growth During Forecast Period

Figure 6.           Asia Pacific: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Asia Pacific Pulmonary Arterial Hypertension Market Impact Analysis of Drivers and Restraint

Figure 9.           Asia Pacific Pulmonary Arterial Hypertension Market– Revenue Forecast and Analysis – 2019 - 2028

Figure 10.        Asia Pacific Pulmonary Arterial Hypertension Market Revenue Share, by Drugs 2021 & 2028 (%)

Figure 11.        Endothelin Receptor Antagonists (ERAs): Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Prostacyclin and Prostacyclin Analogs: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        sGC Stimulators: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Pde-5 Dipsticks: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Asia Pacific Pulmonary Arterial Hypertension Market, by Type 2021 & 2028 (%)

Figure 16.        Branded: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Generics: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Asia Pacific Pulmonary Arterial Hypertension Market Revenue Share, by Route of Administration 2021 & 2028 (%)

Figure 19.        Oral: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Intravenous/ Subcutaneous: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Inhalational: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Asia Pacific Pulmonary Arterial Hypertension Market Revenue Share, by Distribution Channel 2021 & 2028 (%)

Figure 23.        Hospital Pharmacies and Clinics: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Online Pharmacies: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Retail Pharmacies: Asia Pacific Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Asia Pacific: Pulmonary Arterial Hypertension Market, by Key Country – Revenue (2021) (US$ Million)

Figure 27.        China: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Japan: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        India: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        South Korea: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Australia: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Rest of Asia Pacific: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)